A new study in the International Journal of Retina and Vitreous reported that use of systemic chemotherapy as a mainstay of treatment for retinoblastoma results in significant decreases in mortality and morbidity. Adding targeted chemotherapy…
Systemic chemotherapy reduces mortality in retinoblastoma: 30-year analysis from Iran | Ophthalmology Times
